CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective

Hye-Lin Kim, Kyung-Ah Kim, Gwang Hyun Choi, Eun Sun Jang, Moran Ki, Hwa Young Choi, Sook-Hyang Jeong

Clin Mol Hepatol. 2022;28(1):91-104. Published online 2021 November 5 DOI: https://doi.org/10.3350/cmh.2021.0236

A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective

Hye-Lin Kim, Kyung-Ah Kim, Gwang Hyun Choi, Eun Sun Jang, Moran Ki, Hwa Young Choi, Sook-Hyang Jeong

Clinical and Molecular Hepatology. 2022;28(1):91-104

Link1

Link2 Link3

Cost-effectiveness of EGCRISC application versus hepatitis C virus mass screening in Egypt

Engy M. El-Ghitany

Journal of Infection and Public Health. 2019;12(3):442-444

Link1 Link2

Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: An experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence

Hui-Fang Hung, Tony Hsiu-Hsi Chen

Vaccine. 2009;27(48):6770-6776

Link1 Link2

Hepatitis B virus infection in South Korea: three decades after universal vaccination

Jin-Wook Kim

The Korean Journal of Internal Medicine. 2013;28(4):408

Link1 Link2 Link3

Cost-effectiveness of new antiviral treatments for non-genotype 1 hepatitis C virus infection in China: a societal perspective

Xia Wei, Jingyu Zhao, Li Yang

BMJ Global Health. 2020;5(11):e003194

Link1

Time for universal screening for hepatitis D? A study describing screening patterns, characteristics and outcomes of hepatitis D virus infection

Rohit Nathani, Bo Hyung Yoon, Carolina Villarroel, Sidra Salman, Dewan Giri, Amreen Dinani, Ilan Weisberg

Journal of Hepatology. 2022;77:S291

Link1 Link2

Screening blood donors for hepatitis C virus: the challenge to consider cost-effectiveness

Philip Kiely

Transfusion. 2015;55(6):1143-1146

Link1 Link2

Cost‐effectiveness of sofosbuvir plus ribavirin therapy for hepatitis C virus genotype 2 infection in South Korea

Wankyo Chung, Kyung‐Ah Kim, Eun Sun Jang, Moran Ki, Hwa Young Choi, Sook‐Hyang Jeong

Journal of Gastroenterology and Hepatology. 2018;34(4):776-783

Link1 Link2 Link3 Link4

Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens

Mark H. Eckman, John W. Ward, Kenneth E. Sherman

Clinical Gastroenterology and Hepatology. 2019;17(5):930-939.e9

Link1 Link2

Cost-effectiveness of one-time screening for hepatitis C virus infection in Korean general population

K.-A. Kim, W. Chung, H.Y. Choi, E.S. Jang, M. Ki, S.-H. Jeong

Journal of Hepatology. 2018;68:S326

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.